Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapy.

Authors :: Spiegel JY
Dahiya S
Jain MD
Tamaresis J
Nastoupil LJ
Jacobs MT
Ghobadi A
Lin Y
Lunning M
Lekakis L
Reagan P
Oluwole O
McGuirk J
Deol A
Goy A
Vu K
Andreadis C
Munoz J
Bennani NN
Vose JM
Dorritie KA
Neelapu SS
Locke FL
Rapoport AP
Hill BT
Miklos DB
Source :: Blood [Blood] 2021 Apr 01; Vol. 137 (13), pp. 1832-1835.
Publication Year :: 2021

Subjects :: Biological Products
Disease Progression
Female
Humans
Immunotherapy, Adoptive
Kaplan-Meier Estimate
Lymphoma, Large B-Cell, Diffuse pathology
Male
Treatment Outcome
Antigens, CD19 therapeutic use
Lymphoma, Large B-Cell, Diffuse therapy

Full Text Access

Tools